TY  - JOUR
AU  - Vegas-Revenga, Nuria
AU  - Calvo-Rio, Vanesa
AU  - Mesquida, Marina
AU  - Adan, Alfredo
AU  - Hernandez, Maria Victoria
AU  - Beltran, Emma
AU  - Valls-Pascual, Elia
AU  - Diaz-Valle, David
AU  - Diaz-Cordoves, Gisela
AU  - Hernandez-Garfella, Marisa
AU  - Martinez-Costa, Lucia
AU  - Calvo, Inmaculada
AU  - Atanes, Antonio
AU  - Linares, Luis F
AU  - Modesto, Consuelo
AU  - Gonzalez-Vela, Carmen
AU  - Demetrio-Pablo, Rosalia
AU  - Aurrecoechea, Elena
AU  - Cordero, Miguel
AU  - Dominguez-Casas, Lucia C
AU  - Atienza-Mateo, Belen
AU  - Martin-Varillas, Jose Luis
AU  - Loricera, Javier
AU  - Palmou-Fontana, Natalia
AU  - Hernandez, Jose L
AU  - Gonzalez-Gay, Miguel A
AU  - Blanco, Ricardo
PY  - 2018
DO  - 10.1016/j.ajo.2018.12.019
UR  - http://hdl.handle.net/10668/13435
T2  - American journal of ophthalmology
AB  - Cystoid macular edema (CME) is a leading cause of blindness. This study assessed the efficacy and safety of tocilizumab (TCZ) in refractory CME. Retrospective case series. Patients with CME secondary to noninfectious uveitis who had inadequate...
LA  - en
PB  - Elsevier
KW  - Sarcoidosis
KW  - Tomography, Optical Coherence
KW  - Treatment Outcome
KW  - Uveitis
KW  - Visual Acuity
KW  - Adolescent
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - Arthritis, Juvenile
KW  - Chorioretinitis
KW  - Female
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Infusions, Intravenous
KW  - Macula Lutea
KW  - Macular Edema
KW  - Male
KW  - Middle Aged
KW  - Receptors, Interleukin-6
KW  - Retrospective Studies
TI  - Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
TY  - research article
VL  - 200
ER  -